The digital pathology market is valued at an estimated USD 0.9 billion in 2023 and is projected to reach USD 1.8 billion by 2028, at a CAGR of 13.6% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, growing applications of digital pathology in drug development and companion diagnostics, growing awareness of early cancer diagnosis in emerging economies, and recommendations for cancer screening. On the other hand, the high costs of digital pathology systems is expected to restrain market growth to a certain extent.
In this report, 25 key players in the digital pathology market were profiled. These include Danaher Corporation (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Indica Labs Inc. (US), Objective Pathology Services Limited (Canada), Sectra AB (Sweden), OptraSCAN (US), Akoya Biosciences, Inc. (US), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Fujifilm Holdings Corporation (Japan), Proscia Inc. (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Mikroscan Technologies, Inc. (US), PathAI (US), Motic Digital Pathology (US), and Kanteron Systems (Spain).
To know about the assumptions considered for the study download the pdf brochure
Danaher Corporation (US): Danaher Corporation held the largest share of 13-15% of the digital pathology market. It offers a comprehensive portfolio of scanners and software. The company operates in the digital market through its subsidiary, namely, Leica Biosystems GmbH (Germany). The company invested about USD 1,745 million in FY 2022 in R&D, up from USD 1,742 million in FY 2021, to introduce innovative technologies in the market. The company’s R&D activities include improving existing products and expanding applications for use. Danaher Corporation operates in Europe, North America, and the Asia Pacific and has 242 manufacturing and distribution facilities worldwide. The company strengthens its position in the market by expanding its product and service offerings through partnerships. For instance, in September 2022, the company partnered with Indica Labs (US) to deliver compatible digital pathology workflow solutions by maintaining file compatibility between Leica Biosystems Aperio GT 450 family of scanners with Indica Labs Halo family of software solutions.
Koninklijke Philips N.V. (Netherlands): In 2022, Philips was the second-largest player in the digital pathology market. The company offers scanners, software, and storage systems for digital pathology. The company focuses on intelligent, integrated solutions (AI-enabled suites of systems, smart devices, software, and services) that help healthcare providers meet clinical, operational, and financial goals. Philips supports clinicians in precision diagnosis by integrating multiple sources of information across imaging, pathology, and genomics to create a comprehensive single-patient view.
Philips strategically focuses on collaborating and partnering with other market players to launch technologically advanced products and expand globally. In line with this, the company collaborated with Proscia (US) to integrate Philips’ iSyntax image format with Proscia’s Concentriq digital pathology platform and suite of AI modules in June 2020. This collaboration is expected to deliver clinical-grade AI applications to pathology laboratories. The company also focuses on product launches to improve its presence in the digital pathology market. For instance, in 2021, the company launched IntelliSite Pathology to provide access to comprehensive and scalable suite of software tools and capabilities in digital pathology.
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsulation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE